3RD ANNUAL HIGHLY POTENT APIS SUMMIT 2023

In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before. Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address. Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems. In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!

Book your place at the Biopharma & Life Sciences Connected conference and exhibition to hear from leading national and international experts in pharmaceutical manufacturing. The biopharma sector in Ireland is experiencing significant challenges around supply chain issues, digital transformation, automation, carbon reduction and regulatory changes.. The central theme of this event is to hear directly from industry leaders and stakeholders who are willing to share challenges and solutions in practice. That means, the spotlight in presentations will be on case studies from pharmaceutical companies - allowing you to benefit from the speakers' experience in their everyday practice. Over 75 leading speakers involved in the development & manufacturing of biopharmaceutical & biotech products & technology will participate in a full day's schedule of keynote talks & panels on the topics shaping the sector. Why Attend Listen to over 75 expert talks and panel debates on the latest industry issues facing the biopharma & life sciences sector. Avail of the excellent networking opportunities with peers throughout the day Network with over 70 exhibitors displaying the latest technology and research Meet with government support agencies and associations Join our Q&A with industry thought leaders

With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe’s leading microbiome organisations are paving the way for drug development! Join us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators will be united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers. We are bringing together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders, oncology, lung disease, hepatic disease, women’s health and more! Now with new interactive sessions such as a reverse pitch opportunity, technology showcase, poster session and guided networking. This unmissable event will provide you with the opportunity to transform your drug development pipelines and meet like-minded individuals to help you along the way.

Welcome To The Industry’s Leading Pharma Contract Manufacturing Event. Pharma Contract Manufacturing is the only event to focus specifically on how to improve CMO selection and partnering. We appreciate the critical role these play in delivering success for both patients and the organisation-at-large. We also appreciate that the bedrock of these relationships is collaboration from both sides, which is why we bring together leading pharmaceutical companies and CMOs to benchmark best practice in this area. Selecting the right CMO partner is the critical decision in getting high-quality products to patients. If this relationship fails, we fail. Our companies and patients can’t afford for us to get this decision wrong. That’s why Pharma IQ is bringing together partners from across the industry to collaborate on how we make these relationships work both now and in the future. Because for the patient to succeed, we need to succeed.